AKIN GUMP STRAUSS HAUER & FELD

Lobbying for MAYNE PHARMA (USA), INC. · Pharmaceutical Company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · North Carolina · House · Senate · $70,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Issues related to coverage of contraceptive products.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem